AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 239 filers reported holding AMICUS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $131,868 | +16.7% | 10,800 | 0.0% | 0.06% | 0.0% |
| Q3 2022 | $113,000 | -7.4% | 10,800 | -5.3% | 0.06% | 0.0% |
| Q2 2022 | $122,000 | +18.4% | 11,400 | -3.8% | 0.06% | +38.1% |
| Q1 2022 | $103,000 | -1.0% | 11,850 | +9.2% | 0.04% | -4.5% |
| Q3 2021 | $104,000 | +5.1% | 10,850 | +6.4% | 0.04% | -30.2% |
| Q4 2019 | $99,000 | -26.7% | 10,200 | 0.0% | 0.06% | -32.3% |
| Q2 2019 | $135,000 | -18.7% | 10,200 | -16.4% | 0.09% | -13.1% |
| Q1 2019 | $166,000 | +39.5% | 12,200 | -1.6% | 0.11% | +18.9% |
| Q4 2018 | $119,000 | -9.8% | 12,400 | +13.8% | 0.09% | +8.4% |
| Q3 2018 | $132,000 | -17.0% | 10,900 | +6.9% | 0.08% | -25.2% |
| Q2 2018 | $159,000 | -1.2% | 10,200 | -4.7% | 0.11% | -2.6% |
| Q1 2018 | $161,000 | 0.0% | 10,700 | -4.5% | 0.11% | +9.6% |
| Q4 2017 | $161,000 | +4.5% | 11,200 | +9.8% | 0.10% | -3.7% |
| Q3 2017 | $154,000 | – | 10,200 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,114,043 | $116,817,000 | 7.46% |
| Parametrica Management Ltd | 597,279 | $6,899,000 | 6.86% |
| Redmile Group, LLC | 22,716,086 | $262,371,000 | 5.96% |
| Perceptive Advisors | 53,118,886 | $613,524,000 | 4.73% |
| Asymmetry Capital Management, L.P. | 716,709 | $8,278,000 | 4.39% |
| CM Management, LLC | 450,000 | $5,198,000 | 3.93% |
| Avoro Capital Advisors LLC | 18,500,000 | $213,675,000 | 3.64% |
| Kynam Capital Management, LP | 573,699 | $6,626,000 | 3.54% |
| SECTORAL ASSET MANAGEMENT INC | 1,242,882 | $14,355,000 | 2.16% |
| Ghost Tree Capital, LLC | 500,000 | $5,775,000 | 2.07% |